Resmed Inc. buy Citigroup Inc.
Start price
18.09.25
/
50%
€229.80
Target price
18.09.26
€279.41
Performance (%)
-23.93%
Price
09:01
€174.80
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -23.93%. This prediction currently runs until 18.09.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -3.704% | -3.704% |
| iShares Core DAX® | 0.224% | 1.805% |
| iShares Nasdaq 100 | 6.047% | 15.716% |
| iShares Nikkei 225® | 5.724% | 12.343% |
| iShares S&P 500 | 2.172% | 7.723% |
Comments by Citigroup_Inc_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $330.00 price target on the stock.
Ratings data for RMD provided by MarketBeat